View Linkedin View Twitter

About Aviceda

Aviceda Therapeutics is a late clinical-stage biotechnology company focused on harnessing the promise of immune cells’ natural checkpoints, which modulate innate and adaptive immune activity that is dysregulated in a diverse range of diseases characterized by chronic non-resolving inflammation.